French and European, Prof of Thoracic Radiation Oncology, Researcher, RCTs, phase 1 drug-RT, ePROM, RWE, NIHR Senior Investigator, mother of 2. Views are my own
World first study using
▶️ AI to autocontour the top of the best
▶️high quality real world data
▶️rapid-learning methodology
▶️opt-out consent process
Funded by @NIHRresearch@TheChristieNHS@_RAPID_RT@RT_physics
🚨ONE IN TWO S2 EP 4 NOW LIVE🚨
🫁 In this ep, we’re focusing on radiotherapy and lung cancer clinical trials
🗣️ Clinical trials with Professor @finn_corinne: How RAPID RT could improve survival rates for lung cancer patients
📺 Watch now on YouTube 👉https://t.co/JfE7ihWy7G
There is no agreement on resectability for
👉 smaller tumours with multi-station N2, or larger tumours with single-station N2.
👉invasive T4-tumours with maximum single-station N2
Another potential indication for statins in stage I-III lung cancer being treated with radiotherapy - to reduce the risk of durva-related accelerated atherosclerosis!
Looking forward to seeing some clinical data next to see if that signal holds...
@finn_corinne@gerryhanna
An important article emphasizing the challenges in drug-radiotherapy trials
Our CONCORDE platform is showcased as an exemplar of innovative and efficient trial design @CRUKresearch@LeedsCTRU
The authors call on @CTEP and @NCI to endorse and support similar approaches
New in our October issue:
Policy Review: Challenges and opportunities for #early phase #clinicaltrials of novel drug–radiotherapy combinations: recommendations from @NRGonc, @ASTRO_org, @RadiologyACR, Sarah Cannon Research Institute, and @ACRORadOnc https://t.co/an7mShDdDP
🚨 Exciting news from @TheChristieNHS
We have introduced a dose limit to the top of the heart for lung cancer patients. But does this mean higher doses to other thoracic organs? 🤔
👉 This new paper shows that’s NOT the case https://t.co/ikg7r0RpyK
@RT_physics@RO_GreenJournal
This link will take you straight to our project
Applying digital healthcare initiatives to make cancer clinical trials more inclusive
https://t.co/XVZ6dPpxFh
Our new paper on analysing patient reported outcome data is out - a collaborative effort we hope will be useful! Free access link: https://t.co/3kt4gyb5w2
@dr_jm_price@finn_corinne@DrKateAbsolom @pao_adventures @yorke_janelle
��� Record-Breaking Abstract Submissions for ESTRO25! 🌟
We’ve received 3452 abstracts— setting a new record! 🚀
Thank you to the incredible radiation oncology community for your contributions. 🙏
Stay tuned for more updates!
#ESTRO25 #Radonc
Unlocking the power of real-world data in UK radiotherapy: overcoming barriers inc accessibility, quality, governance is key
Streamlined processes, data science training, and prioritisation are essential steps
@RT_physics@RCRadiologists
Read more 👉https://t.co/WClqeFa0EP
🔥off the press👉 We have defined a new cardiac anatomical region at risk for radiotherapy
The cardiac avoidance area is described and an atlas provided to facilitate implementation @KathrynBanfill@TheChristieNHS@MCRCnews
https://t.co/gHXFaMTXDG
Many thanks to @CRUKresearch for renewing the funding for our joint @TheChristieNHS@MCRCnews@ucl Lung Cancer Centre of Excellence
Looking forward to exciting collaborations leading to improvements in patients outcome in the next 5 years
Role PCI SCLC uncertain in Immunotherapy era
· ADRIATIC LSSCLC trial ↑↑OS/PFS w/Durva
· Use PCI ↑↑ outcomes (strat factor)
· PCI Yes ↑↑PFS 28 mo vs 9/OS NR vs 37mo
Support ongoing trials EORTC PRIMALung & SWOG MAVERICK MRI surveillance +/- (HA)PCI https://t.co/iwqpqzZir7
Interested in reading about the role of PCI in the era on immunotherapy ? 👉 please read our latest paper published in @JTOonline and 🙏🏽enrol patients in the PRIMALUNG @EORTC and MAVERICK @SWOG trials
@PDBrownOnc
PCI for Patients with Small Cell Lung Cancer: A New Perspective in the Immunotherapy Era Out on JTO
Prophylactic cranial irradiation (PCI) has been used in small-cell lung cancer (SCLC) to reduce brain metastases and improve survival, but recent immunotherapy trials have limited data on its impact. The ADRIATIC trial showed better outcomes for patients receiving PCI alongside consolidation immunotherapy in limited-stage SCLC. Ongoing studies like EORTC-1901 PRIMALung and SWOG 1827-MAVERICK are investigating PCI’s role in the immunotherapy era, highlighting its potential continued importance in treatment strategies.
@finn_corinne@MKnoll_MD@HenningWillers@fumikochino@_ShankarSiva@PercyLeeMD@Icro_Meattini @DrChowdharyMD @DrLesterColl@ErinGillespieMD@seanmmcbride@NiuSanford@acampsmalea@to_be_elizabeth
https://t.co/IXkOsn8IrG
Urgent need for evidence on the role of PCI and MRI surveillance in all stages of Small Cell Lung Cancer in the era of immunotherapy
👉Please consider enrolling patients in the @EORTC PRIMALUNG trial to contribute to advancing outcomes
https://t.co/lkWYEXrN6t
⏳ Only 2 weeks left to submit your abstract for ESTRO 2025! Don’t miss the chance to showcase your research in #RadOnc. Submit now!
📅Deadline: 20 November 2024
🔗 https://t.co/GUw4hphzVu
#ESTRO25